vs

Side-by-side financial comparison of Organogenesis Holdings Inc. (ORGO) and Porch Group, Inc. (PRCH). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $121.1M, roughly 1.9× Porch Group, Inc.). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs -3.9%, a 23.3% gap on every dollar of revenue. On growth, Porch Group, Inc. posted the faster year-over-year revenue change (100.0% vs 78.1%). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 26.4%).

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

Porch is a website that tries to connect homeowners with local home improvement contractors. The site features advice articles, cost guide, and online booking for over 160 home projects.

ORGO vs PRCH — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.9× larger
ORGO
$225.6M
$121.1M
PRCH
Growing faster (revenue YoY)
PRCH
PRCH
+21.9% gap
PRCH
100.0%
78.1%
ORGO
Higher net margin
ORGO
ORGO
23.3% more per $
ORGO
19.4%
-3.9%
PRCH
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
26.4%
PRCH

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ORGO
ORGO
PRCH
PRCH
Revenue
$225.6M
$121.1M
Net Profit
$43.7M
$-4.7M
Gross Margin
52.7%
Operating Margin
28.1%
Net Margin
19.4%
-3.9%
Revenue YoY
78.1%
100.0%
Net Profit YoY
469.5%
2.0%
EPS (diluted)
$0.31
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORGO
ORGO
PRCH
PRCH
Q1 26
$121.1M
Q4 25
$225.6M
$112.3M
Q3 25
$150.9M
$115.1M
Q2 25
$101.0M
$107.0M
Q1 25
$86.7M
$84.5M
Q4 24
$126.7M
$75.3M
Q3 24
$115.2M
$77.7M
Q2 24
$130.2M
$75.9M
Net Profit
ORGO
ORGO
PRCH
PRCH
Q1 26
$-4.7M
Q4 25
$43.7M
$-3.5M
Q3 25
$21.6M
$-10.9M
Q2 25
$-9.4M
$2.6M
Q1 25
$-18.8M
$8.4M
Q4 24
$7.7M
$30.5M
Q3 24
$12.3M
$14.4M
Q2 24
$-17.0M
$-64.3M
Gross Margin
ORGO
ORGO
PRCH
PRCH
Q1 26
52.7%
Q4 25
99.5%
Q3 25
75.6%
Q2 25
70.9%
Q1 25
72.6%
77.4%
Q4 24
75.5%
Q3 24
76.7%
79.4%
Q2 24
77.6%
22.1%
Operating Margin
ORGO
ORGO
PRCH
PRCH
Q1 26
Q4 25
28.1%
14.7%
Q3 25
13.7%
14.2%
Q2 25
-12.5%
4.7%
Q1 25
-30.9%
-1.5%
Q4 24
8.1%
33.3%
Q3 24
5.4%
-3.2%
Q2 24
-10.7%
-69.2%
Net Margin
ORGO
ORGO
PRCH
PRCH
Q1 26
-3.9%
Q4 25
19.4%
-3.1%
Q3 25
14.3%
-9.4%
Q2 25
-9.3%
2.4%
Q1 25
-21.7%
9.9%
Q4 24
6.1%
40.5%
Q3 24
10.7%
18.5%
Q2 24
-13.1%
-84.8%
EPS (diluted)
ORGO
ORGO
PRCH
PRCH
Q1 26
$-0.04
Q4 25
$0.31
$0.00
Q3 25
$0.11
$-0.10
Q2 25
$-0.10
$0.00
Q1 25
$-0.17
$0.07
Q4 24
$0.05
$0.34
Q3 24
$0.09
$0.12
Q2 24
$-0.13
$-0.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORGO
ORGO
PRCH
PRCH
Cash + ST InvestmentsLiquidity on hand
$93.7M
$68.4M
Total DebtLower is stronger
$391.3M
Stockholders' EquityBook value
$300.1M
$26.3M
Total Assets
$598.7M
$806.6M
Debt / EquityLower = less leverage
14.87×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORGO
ORGO
PRCH
PRCH
Q1 26
$68.4M
Q4 25
$93.7M
$57.3M
Q3 25
$63.7M
$85.0M
Q2 25
$73.1M
$79.8M
Q1 25
$110.0M
$70.4M
Q4 24
$135.6M
$191.7M
Q3 24
$94.3M
$238.6M
Q2 24
$89.9M
$308.4M
Total Debt
ORGO
ORGO
PRCH
PRCH
Q1 26
$391.3M
Q4 25
$392.8M
Q3 25
$387.1M
Q2 25
$394.1M
Q1 25
$409.2M
Q4 24
$403.9M
Q3 24
$62.3M
$399.0M
Q2 24
$63.8M
$436.8M
Stockholders' Equity
ORGO
ORGO
PRCH
PRCH
Q1 26
$26.3M
Q4 25
$300.1M
$-24.6M
Q3 25
$255.1M
$-27.9M
Q2 25
$233.2M
$-29.3M
Q1 25
$242.9M
$-52.4M
Q4 24
$262.9M
$-43.2M
Q3 24
$278.5M
$-77.0M
Q2 24
$263.5M
$-101.9M
Total Assets
ORGO
ORGO
PRCH
PRCH
Q1 26
$806.6M
Q4 25
$598.7M
$797.4M
Q3 25
$509.8M
$787.7M
Q2 25
$461.1M
$770.7M
Q1 25
$467.4M
$802.3M
Q4 24
$497.9M
$814.0M
Q3 24
$446.3M
$867.3M
Q2 24
$443.2M
$876.1M
Debt / Equity
ORGO
ORGO
PRCH
PRCH
Q1 26
14.87×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ORGO
ORGO
PRCH
PRCH
Operating Cash FlowLast quarter
$39.4M
Free Cash FlowOCF − Capex
$34.8M
FCF MarginFCF / Revenue
15.4%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ORGO
ORGO
PRCH
PRCH
Q1 26
Q4 25
$39.4M
$1.2M
Q3 25
$3.1M
$40.8M
Q2 25
$-32.9M
$35.6M
Q1 25
$-19.9M
$-11.2M
Q4 24
$10.9M
$-26.6M
Q3 24
$8.7M
$12.4M
Q2 24
$4.7M
$-26.0M
Free Cash Flow
ORGO
ORGO
PRCH
PRCH
Q1 26
Q4 25
$34.8M
$1.1M
Q3 25
$844.0K
$40.7M
Q2 25
$-36.5M
$35.4M
Q1 25
$-23.6M
$-11.2M
Q4 24
$7.6M
$-26.8M
Q3 24
$6.1M
$12.2M
Q2 24
$2.9M
$-26.0M
FCF Margin
ORGO
ORGO
PRCH
PRCH
Q1 26
Q4 25
15.4%
1.0%
Q3 25
0.6%
35.4%
Q2 25
-36.1%
33.0%
Q1 25
-27.2%
-13.3%
Q4 24
6.0%
-35.6%
Q3 24
5.3%
15.7%
Q2 24
2.2%
-34.3%
Capex Intensity
ORGO
ORGO
PRCH
PRCH
Q1 26
Q4 25
2.1%
0.1%
Q3 25
1.5%
0.1%
Q2 25
3.6%
0.2%
Q1 25
4.2%
0.1%
Q4 24
2.7%
0.3%
Q3 24
2.2%
0.3%
Q2 24
1.4%
0.1%
Cash Conversion
ORGO
ORGO
PRCH
PRCH
Q1 26
Q4 25
0.90×
Q3 25
0.14×
Q2 25
13.79×
Q1 25
-1.33×
Q4 24
1.43×
-0.87×
Q3 24
0.71×
0.86×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons